Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study

Cancer. 1983 Apr 15;51(8):1339-47. doi: 10.1002/1097-0142(19830415)51:8<1339::aid-cncr2820510803>3.0.co;2-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols*
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Clinical Trials as Topic
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drug Therapy, Combination
  • Female
  • Hodgkin Disease / drug therapy*
  • Humans
  • Male
  • Mechlorethamine / administration & dosage
  • Mechlorethamine / adverse effects
  • Middle Aged
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Procarbazine / administration & dosage
  • Procarbazine / adverse effects
  • Prognosis
  • Random Allocation
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Antineoplastic Agents
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Doxorubicin
  • Prednisone

Supplementary concepts

  • MOP-BAP protocol
  • MOPP-Bleo protocol